Fig 1.
Box plot comparing the absolute FEV1 annual change in patients with normal (27%) or abnormal (73%) rate of FEV1 decline.
For further explanations, see text.
Table 1.
Main characteristics (%, mean±SD or median [IQR]) of participants (n = 188) at recruitment and after 6 years follow-up.
Table 2.
Comparison of main demographic, clinical and lung function characteristics (%, mean±SD or median [IQR]) in patients with a normal (<30ml/yr) or increased (≥30ml/yr) rate of FEV1 decline, both at recruitment and end of six years follow-up.
Among variables included in Table 1, only those with p value < 0.05 in the Bivariate analysis are shown.
Table 3.
Univariate and multivariable analysis of predictive factors of increased rate (≥30 ml/yr) of FEV1 decline in HIV patients.
Among variables included in Table 1, only those with p value < 0.05 in the Bivariate analysis are shown.
Table 4.
Predictors of FEV1 decline (considered as a continuous variable).
Among variables included in Table 1, only those with p value < 0.10 in the Bivariate analysis are shown.
Fig 2.
FEV1 trajectories from baseline to end of follow-up in participants with normal (left) or accelerated decliners in addition to the FEV1 changes (right) stratified by smoking status at the end of follow up (never (green line), former (yellow line) and current smokers (red line). The annualized rates of FEV1 decline within each group were not significantly different. For further explanations, see text.
Table 5.
Statistically significant differences between current vs. never and former smokers at the end of follow-up.
Variables included in Table 1 not shown here were not significantly different between these two groups at this time point.